Ommi Ojaswitha

Assistant Professor, Pharmacy, GSP, HYD

oommi@gitam.edu | | | |

Ojaswitha Ommi received her bachelor's degree in pharmacy in 2016 and earned a master's degree in pharmacy with a specialization in Medicinal Chemistry from NIPER, Hyderabad. She completed her Ph.D. in Medicinal Chemistry at NIPER, Hyderabad, under the supervision of Dr. Y. V. Madhavi. Her research revolves around the design and synthesis of small molecules with anticancer and antimicrobial profiles.

Research Publications
  • Ommi, O.; Naiyaz Ahmad, M.; Gajula, S. N. R.; Wanjari, P.; Sau, S.; Agnivesh, P. K.; Sahoo, S. K.; Kalia, N. P.; Sonti, R.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M., Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and Mycobacterium tuberculosis. RSC Medicinal Chemistry 2023, 14 (7), 1296-1308.
  • Ommi, O.; Chilvery, S.; Dhopat, P. S.; Sharma, A.; Bhalerao, H. A.; Dannaram, S. R.; Nanduri, S.; Sonti, R.; Godugu, C.; Yaddanapudi, V. M., Exploration of quinoxaline-benzimidazole hybrids as apoptosis-inducing agents and tubulin polymerisation inhibitors. Journal of Molecular Structure 2023, 1292, 136184.
  • Ommi, O.; Paoletti, N.; Bhalerao, H. A.; Nanduri, S.; Mohammed A; Sonti, R.; Supuran, C. T.; Yaddanapudi, V. M., Exploration of 3-aryl pyrazole tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors, Archiv der pharmazie, under revision
  • S. K. Sahoo, O. Ommi, S. Maddipatla, P. Singh, M. N. Ahmad, G. Kaul, S. Nanduri, A. Dasgupta, S. Chopra, V. M. Yaddanapudi. Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents. Mol Divers 2022. https://doi.org/10.1007/s11030-022-10543-0.
  • • Baliram Gaikwad, N.; Kumar Sahoo, S.; Ommi, O.; Naiyaz Ahmad, M.; Pathan, A.; Kaul, G.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Madhavi Yaddanapudi, V., Identification of 1,3-Substituted Pyrazole-Based Carboxamide Derivatives as Potent Antitubercular Agents. ChemistrySelect 2022, 7 (40), e202203333.
Expertise
  • Medicinal Chemistry
  • drug design, synthesis
  • Molecular modelling
Ommi Ojaswitha